Vanguard Global Advisers »

Haemonetics Corporation shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 19k 56.36

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Haemonetics Corporation

BlackRock
Vanguard Group
Neuberger Berman Group
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
River Road Asset Management
FMR
Dimensional Fund Advisors
Geode Capital Management
North Peak Capital Management
Goldman Sachs Group
T. Rowe Price Investment Management

View all funds holding Haemonetics Corporation